New Data and Emerging Management Strategies for Migraine Headache

STATEMENT OF NEED Migraine is a type of chronic headache disorder characterized by headaches of a stabbing, pulsatile quality that last between 4 and 72 hours each, often accompanied by symptoms of nausea and sensitivity to light and noise. An estimated 1.04 billion individuals have been diagnosed with migraine worldwide (Negro et al, 2019). Patients report that migraine impacts virtually every aspect of their lives, including personal relationships, reproductive choices, and productivity i...
i3 Health

Applying Precision Medicine in BRAF V600E–Mutant Metastatic Colorectal Cancer

STATEMENT OF NEED Colorectal cancer is the second leading cause of cancer death among men and women in the United States (ACS,2021). An estimated 149,500 new cases are diagnosed annually, and 52,980 people die of the disease (ACS, 2021). When detected and treated early at a localized stage, the 5-year survival rate is 90%. However, because colorectal cancer initially exhibits no symptoms and the use of routine screening is suboptimal, most patients are diagnosed at later stages (ACS, 2021)....
i3 Health

Advanced Ovarian Cancer and PARP Inhibitors: Clinical Insights and Impact on New Data

In this CME activity, Susana M. Campos, MD, MS, MPH, reviews some of the recent clinical developments in the treatment of patients with advanced ovarian cancer with PARP inhibitors. We welcome you to learn more about the updated data from key clinical studies of PARP inhibitor maintenance therapy in advanced ovarian cancer, and the implications of the results on the current and emerging concepts in ovarian cancer clinical practice. CONTENT AREAS • Platinum-sensitive recurrent ovarian cance...
Annenberg Center for Health Sciences at Eisenhower

Video Viewpoint Strategy Session: Optimizing Treatment and Functional Outcomes in Head and Neck Squamous Cell Carcinoma

Gain expert insight on emerging treatment approaches for patients with head and neck squamous cell carcinoma, incuding the safety and tolerabilty of emerging treatments, survivorship care, and much more. This activity is presented by leading experts, Barbara Burtness, MD, Professor of Medicine at Yale School of Medicine and Smilow Cancer Hospital, and Lynsey Teulings, NP, Nurse Practitioner at Yale School of Medicine and Smilow Cancer Hospital. Start the activity now. STATEMENT OF NEED H...
i3 Health

Best Practices in the Management of Tumor Lysis Syndrome Associated With Emerging Cancer Therapies

Explore best practices in the management of tumor lysis syndrome associated with emerging cancer therapies. This activity, presented by Matthew S. Davids, MD, MMSc, Director of Clinical Research at Dana-Farber Cancer Institute, and Amy Goodrich, RN, BSN, MSN, CRNP-AC, Nurse Practitioner at Johns Hopkins Kimmel Cancer Center, will review plans to optimize prevention, recognition, and treatment, as well as discuss emerging therapies and monitoring strategies for patient care. Start the activity ...
i3 Health

Embracing Novelty in HFrEF: Optimizing Outcomes in Patients with Symptomatic, High-Risk HF

This adaptive and interactive 3-part webcast series is targeted to cardiologists and primary care physicians, alongside their interprofessional heart failure care team of nurse practitioners (NPs) and physician assistants (PAs). Moderated by Dr. Muthu Vaduganathan, cardiologist at Brigham and Women’s Hospital and faculty at Harvard Medical School, joined by Drs. Javed Butler, Michelle Kittleson, and Amulya Nagarur, each webcast will focus on exploring the different facets of HFrEF that lead ...
CE Concepts

Medical Moments Webcast Series: Promising Options for HER2+ Gastric Cancer Treatment: Focus on Emerging ADCs

This three-part webcast series is targeted to medical oncologists, molecular pathologists, and other clinicians who are involved in diagnosis and treatment of HER2+ gastric cancer. Moderated expertly by the series Chair, Dr. David Ilson from Memorial Sloan Kettering, our knowledgeable faculty will examine the latest testing guidelines and clinical trial data, exploring the burgeoning evidentiary base in support of an expanded role for antibody-drug conjugates in oncology, and specifically in H...
CE Concepts

Applying ADAURA in Practice: Implications For Early Stage EGFRM NSCLC

This educational initiative is targeted to medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists and molecular pathologists who are involved in diagnosis of early stage NSCLC that is surgically resectable with curative intent. In addition to examining the latest ADAURA trial data and the potential utility of adjuvant osimertinib in stage IB-IIIA EGFRm NSCLC, the practice-changing implications of these results will also be explored from a variety of perspectives with thr...
CE Concepts

Podcast: Update on Immunotherapeutic Strategies for Recurrent and Metastatic Cervical Cancer

In this episode of Oncology Data Advisor TM, learn more about emerging immunotherapies for the treatment of recurrent and metastatic cervical cancer, strategies to monitor and manage adverse events, and developments in the standard of care for patients wth cervical cancer. This activity is presented by leading experts, Bradley Monk, MD, FACS, FACOG, University of Arizona College of Medicine, and Jennifer Filipi, MSN, FNP-C, Massachusetts General Hospital. Listen now! STATEMENT OF NEED Th...
i3 Health

Video Viewpoint Strategy Session: Update on Immunotherapeutic Strategies for Recurrent and Metastatic Cervical Cancer 

Learn more about emerging immunotherapies for the treatment of recurrent and metastatic cervical cancer, strategies to monitor and manage adverse events, and developments in the standard of care for patients wth cervical cancer. This activity is presented by leading experts, Bradley Monk, MD, FACS, FACOG, University of Arizona College of Medicine, and Jennifer Filipi, MSN, FNP-C, Massachusetts General Hospital. Start the activity now! STATEMENT OF NEED There are an estimated 13,800 new c...
i3 Health

Addressing Challenges in Diagnosis and Treatment of Low-Grade Upper Tract Urothelial Carcinoma

OVERVIEW Upper tract urothelial carcinoma (UTUC) has many similarities to bladder carcinoma, but also some important differences. Join Dr. Seth Lerner, as he contrasts these 2 diseases, as well as important differences between low-grade and high-grade UTUC. Dr. Lerner highlights important considerations in the instruments, imaging, and biopsy techniques for diagnosing low-grade UTUC. Surgical options are considered, with a focus on patient selection for endoscopic nephron-sparing surgery. The...
Annenberg Center for Health Sciences at Eisenhower

Clinical Diversity and Genetic Variation in Lysosomal Disorders

Explain the principles of Pathogenic Processes in LSDs. Explain that lysosomal composition, shape, contents, numbers differ between cell types and have an effect on disease expression. Review the evolving understanding of lysosomal autophagy functions.
CheckRare

Video ViewPoint Strategy Session: Rethinking the Management of Differentiated and Anaplastic Thyroid Cancers

Gain expert insight and strategies for the management of anaplastic thyroid cancer including emerging data on immunotherapies, and treatment to manage adverse events. This activity is presented by leading experts, Jochen Lorch, MD, MSc, Director Thyroid Cancer Center, Dana-Farber Cancer Institute, and Carolyn Grande, CRNP, AOCNP®, Oncology Nurse Practitioner, Abramson Cancer Center. STATEMENT OF NEED Thyroid cancer is one of the most prevalent cancers in the United States. An estimated ...
i3 Health

Metastatic Triple-Negative Breast Cancer: Applying Treatment Advances to Personalized Care

Sara A. Hurvitz, MD, FACP, Director of the Breast Cancer Clinical Trials Program at the David Geffen School of Medicine at UCLA, and a prominent authority on TNBC, provides perspectives on personalized care plans for patients with metastatic TNBC, efficacy and safety of emerging treatments, strategies to improve quality of life for patients with metastatic TNBC, and much more! Start the activity now! STATEMENT OF NEED With an estimated 284,200 new cases per year, breast cancer is the mo...
i3 Health

Exploring Best Practices for Diagnosis and Management of Adult-Onset Stills Disease

Adult-onset Still’s disease (AOSD) is a rare, polygenic autoinflammatory syndrome with a pathogenesis similar to systemic juvenile inflammatory arthritis. Join Drs. Petros Efthimiou and Olga Petryna as they discuss making the diagnosis of AOSD through interpretation of clinical and laboratory findings and careful exclusion of other diseases. The faculty review the evidence related to the variety of medications often used to treat patients with AOSD, focusing on canakinumab, the only medicati...
Annenberg Center for Health Sciences at Eisenhower

Exploring Best Practices for Diagnosis and Management of Hypereosinophilic Syndrome

Hypereosinophilic syndromes (HESs) are a broad group of disorders that can lead to serious complications, including cardiovascular disease, cerebrovascular disease, and death. Due to their rarity, however, HESs are challenging to diagnose and treat. In this in-depth review, presented by Princess Ogbogu, MD, and developed in collaboration with Michael Wechsler, MD, MMSc, the wide-ranging presentations of HES will be reviewed, along with pathophysiology, classification, and acute and chronic man...
Annenberg Center for Health Sciences at Eisenhower

Podcast: Novel and Emerging Treatment Strategies for Advanced Classical Hodgkin Lymphoma

Discover new and emerging treatment strategies for advanced classical Hogkin lymphoma, personalized care plans, and best practices for managing supportive care need. This activity is presented by leading experts Kami Maddocks, MD, Professor of Clinical Internal Medicine, Lymphoma Program Director, The James Cancer Hospital at The Ohio State University, and Kelly Brassil, PhD, RN, FAAN, Advanced Practice Nurse, University of Texas MD Anderson Cancer Center. Start the activity now! STATEMENT ...
i3 Health

Video Viewpoint Strategy Session: Novel and Emerging Treatment Strategies for Advanced Classical Hodgkin Lymphoma

Discover new and emerging treatment strategies for advanced classical Hogkin lymphoma, personalized care plans, and best practices for managing supportive care need. This activity is presented by leading experts Kami Maddocks, MD, Professor of Clinical Internal Medicine, Lymphoma Program Director, The James Cancer Hospital at The Ohio State University, and Kelly Brassil, PhD, RN, FAAN, Advanced Practice Nurse, University of Texas MD Anderson Cancer Center. Start the activity now! STATEMENT ...
i3 Health

Acromegaly Highlights from ENDO 2021

This CME activity highlights the latest research about Acromegaly that was presented at ENDO 2021, the annual meeting of the Endocrine Society. This activity provides expert analysis on that research and its clinical relevance for busy members of the care team in order to help them care for patients with acromegaly.
CheckRare

Emerging Treatment Strategies for Advanced Cholangiocarcinoma 

This in-depth discussion, presented by Lipika Goyle, MD, Massachusetts General Hospital, will feature expert insights on emerging therapeutic treatments, recent discoveries on novel therapies, managing strategies for monitoring and managing adverse events, and much more! Start the activity now! STATEMENT OF NEED Cholangiocarcinoma, also known as bile duct cancer, is a rare malignancy originating in the epithelium of the bile duct. Accounting for only 3% of gastrointestinal tumors, it is ...
i3 Health

Video Viewpoint Strategy Session: Advances in the Treatment of Relapsed/Refractory Immune Thrombocytopenia

Learn new advances in the treatment of relapsed or refractory immune thrombocytopenia, including treatment differentiation, efficacy and safety strategies, and much more. This activity features perspectives from two noted experts in the field, Dr. Keith McCrae, Director of Benign Hematology at the Cleveland Clinic Taussig Cancer Center; and Ms. Phyllis McKiernan, Advanced Practice Nurse in Blood & Marrow Stem Cell Transplantation at the John Theurer Cancer Center, Hackensack Meridian Health. ...
i3 Health

Oncology Nursing Showdown! Aggressive Non–Hodgkin Lymphoma Edition: Module 3 - Peripheral T-Cell Lymphoma

In the third segment of this three-part series, Maria Badillo, MSN, RN, OCN®, CCRP, Research Nurse Manager, MD, Anderson Cancer Center, evaluates guideline recommendations for the management of peripheral T-cell lymphoma (PTCL), assesses emerging data on novel therapies, and applies strategies to optimize treatment experiences for patients. For more expert insights on aggressive non-hodgkin lymphoma, complete modules 2 and 3. Start the activity now! Each year, 81,560 new cases of non-Hod...
i3 Health

Oncology Nursing Showdown! Aggressive Non–Hodgkin Lymphoma Edition: Module 2 - Mantel Cell Lymphoma

In the second segment of this three-part series, Maria Badillo, MSN, RN, OCN®, CCRP, Research Nurse Manager, MD Anderson Cancer Center, shares expert insights on guideline recommendations for optimizing individual patient care, efficacy and safety data, and strategies to manage adverse event for patients with advanced aggressive mantle cell lymphoma (MCL). For more expert insights on aggressive non-Hodgkin lymphoma, complete modules 1 and 3. Start the activity now! Each year, 81,560 new c...
i3 Health

Oncology Nursing Showdown! Aggressive Non–Hodgkin Lymphoma Edition: Module 1 - Diffuse Large B-Cell Lymphoma

In the first segment of this three-part series, Maria Badillo, MSN, RN, OCN®, CCRP, Research Nurse Manager, MD Anderson Cancer Center, evaluates guideline recommendations for the management of patients with advanced diffuse large B-cell lymphoma (DLBCL). Learners will receive expert insight on assessing emerging data on novel therapies, strategies to manage adverse events, and optimizing treatment for patients with advanced DLBCL. Complete modules 2 and 3 for more in-depth knowledge of ag...
i3 Health

Enhancing the Clinical Outcomes of Patients with Extensive–Stage Small Cell Lung Cancer

Anne Chiang, MD, PhD, Yale School of Medicine, a leading expert on small cell lung cancer, for an in-depth presentation on patient outcomes in extensive-small cell lung cancer. Dr. Chiang will present evidence-based advice regarding emerging therapies, strategies for targeted treatments and immunotherapy, optimization of individual patient treatment plans, managing adverse events, and much more! Start the activity now! An estimated 228,820 new cases of lung cancer are reported in the United...
i3 Health

New Perspectives on Diagnosis and Treatment of EGFR Exon 20 Insertion–NSCLC

Discover new developments in the diagnosis and treatment of EGFR exon-20 Insertion–Mutant NSCLC and assess emerging efficacy and safety data on novel targeted therapies. This activity features expert insights from Helena Yu, MD, Memorial Sloan Kettering Cancer Center, and Maria Arcila, MD, Memorial Sloan Kettering Cancer Center. This activity is also available as a podcast. An estimated 235,760 new cases of lung cancer are reported in the United States annually, and 131,880 people die...
i3 Health

Current and Emerging Therapies for Lysosomal Storage Disease

This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available for other attendees.
CheckRare

An Interactive Guide to the Underdiagnosed, Underestimated, but Treatable Metabolic Disorders

This infographic activity uses a self-directed, visual update to the state-of-the-art diagnosis and management of treatable lysosomal storage disorders. Much of what you learned in your primary training may be outdated because of rapid advances in genetic, molecular, and clinical approaches to these conditions. While the LSDs were often fatal conditions, new treatments have completely changed the possible outcomes for patients, but a major barrier is recognition of the condition in time for tr...
Annenberg Center for Health Sciences at Eisenhower

New Opportunities in Advanced KRAS Mutation-Positive NSCLC

In this CME/NCPD activity, D. Ross Camidge, MD, PhD, of the University of Colorado, and Beth Sandy, MSN, CRNP, OCN®, of the University of Pennsylvania, discuss novel treatments for advanced KRAS mutation-positive NSCLC and how to manage adverse events associated with small molecule inhibitors. Start now!  An estimated 228,820 new cases of lung cancer are reported in the United States annually, and 135,720 people die of the disease (ACS, 2020). Approximately 84% of cases are classified as...
i3 Health

Fabry Disease Research Highlights

At WORLDSymposium 2021, new information and data were presented on Fabry disease, a rare lysosomal storage disorder. This CME activity highlights the latest information about Fabry disease from WORLDSymposium 2021 and provides expert analysis of its clinical relevance for busy members of the care team in order to help them care for patients with this rare condition.
CheckRare

Gaucher Disease Research Highlights: ASH 2020

At the American Society of Hematology Annual Meeting (ASH 2020), new information and data were presented on Gaucher disease, a rare lysosomal storage disorder, that requires a team of health care professionals to properly manage. This CME activity highlights the latest information about Gaucher disease from ASH 2020 and provides expert analysis of its clinical relevance for busy members of the care team in order to help them care for patients with this rare condition. Activity Faculty
CheckRare

Meeting the Challenges in Management of Sickle Cell Disease

No longer a life-threatening disease, sickle cell disease (SCD) has become a chronic disease with life-threatening events that requires coordinated care by a multidisciplinary care team. Join Michael R. DeBaun, MD, MPH, and Collin Montgomery, APRN, as they discuss the acute and chronic complications experienced by individuals with SCD and the barriers they often encounter. The faculty offer real-world strategies for overcoming these barriers to improve the quality of life and other health outc...
Annenberg Center for Health Sciences at Eisenhower

Update on Therapeutic Advances in T-Cell Lymphoma

Join Steven M. Horwitz, MD, Member and Attending Physician at Memorial Sloan Kettering Cancer Center, as he discusses guideline recommendations for differential diagnosis of TCL, novel treatment strategies, and best practices for managing side effects in this case-based CME/NCPD activity! STATEMENT OF NEED Each year, 74,240 new cases of non-Hodgkin lymphoma are diagnosed and 19,940 people die of the disease (ACS, 2020). Among these cases, 12% to 15% are classified as peripheral T-cell l...
i3 Health

Optimizing the Management of Moderate-to-Severe Atopic Dermatitis in Adult Patients

STATEMENT OF NEED Atopic dermatitis is a severe form of eczema pathologically characterized by skin barrier disruption mediated by a type 2 helper T-cell immune response. The incidence of atopic dermatitis is high, estimated to be approximately 15% to 20% in children and 1% to 3% in adults worldwide (Avena-Woods, 2017). In addition to the hallmark clinical symptoms of eczema and intense pruritus, atopic dermatitis is associated with a substantial and multifaceted patient-reported burden tha...
i3 Health

Expert Updates in COVID19: An Animated Video Series

Five animated videos clearly explain managing patients with COVID19, lung disease, ARDS, or long-COVID. Hear from the leading pulmonologists on best practices based on the latest literature.
The France Foundation

Assessing a Patient With Long COVID-19: An Interactive Case Scenario

In this interactive case, the physician recommends a series of assessments for your patient with Long-COVID symptoms. For each assessment, the user chooses the outcome to hear recommendations from the experts.
The France Foundation

TEAM UP: Defining and Refining Optimal HIV Care During the COVID-19 Pandemic

In this webcast series, members of the DAP Health team review key data and discuss their real-world experiences providing care for persons living with HIV during the COVID-19 pandemic. DAP Health opened one of California’s first COVID-19 clinics and hotlines to offer screening, testing, and treatment. Topics covered in this webcast series include: COVID-19–Related Complications in Persons Living With HIV (PLWH); COVID-19 Testing Strategies; Home Care for PLWH Diagnosed With COVID-1...
Annenberg Center for Health Sciences at Eisenhower

Eye on Neuromyelitis Optica Spectrum Disorder (NMOSD)

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease often characterized by sporadic and repeated inflammatory flare ups that can impact the optic nerve and/or spinal cord. With each repeated attack, additional permanent neurological damage will accrue. This CME activity highlights the important role both ophthalmologists and neurologists play in diagnosing and treating NMOSD most efficiently.
CheckRare

Pulmonary Arterial Hypertension (PAH) Highlights from CHEST 2020

Although CHEST 2020 was not a live, in-person meeting, new information and data regarding pulmonary arterial hypertension (PAH) will still be published but will not be easily accessible to the care team involved in the diagnosis and management of patients with this rare disease who need to know and incorporate the latest information into patient care. This CME activity highlights the latest research on PAH to help clinicians keep up to date on the most efficient ways to manage their patients.
CheckRare

Understanding Evolving Therapeutic Strategies for Graft-Versus-Host Disease (Module 1: Diagnosis, Risk Assessment, and Staging; Module 2: Current and Emerging Therapeutic Strategies)

STATEMENT OF NEED Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplant (HSCT), affecting between 40% and 60% of patients and accounting for 15% of posttransplant mortality. Acute GVHD is the second-leading cause of transplant-related mortality and typically targets the skin, gastrointestinal tract, and liver. Chronic GVHD often presents during the first year following HSCT but may develop in subsequent years and most commonly affects the ...
i3 Health

Optimal Prehospital Management of Seizure Emergencies

In this program, the faculty will review and provide updates on the guidelines for managing seizure emergencies and address how participants can reduce the barriers to prehospital treatment through the use of Seizure Action Plans. They also will discuss recent clinical trials that may improve caregiver acceptance of rescue medications for status epilepticus. In addition, the faculty will address the similarities and differences in managing seizure emergencies for pediatric and adult patients.
Annenberg Center for Health Sciences at Eisenhower

Research Updates in Gout: Improving Response Rate to Therapy

Dr. Brian Mandell and Dr. Naomi Schlesinger discuss recent published evidence related to gout, as well as study results presented at the American College of Rheumatology Convergence 2020 virtual annual meeting. Dr. Schlesinger begins with an introduction on a recent published systematic review indicating that the manifestations of gout extend beyond the joints, affecting other organs and tissues. Dr. Schlesinger also provides an overview of some of the challenges encountered in clinical practi...
Annenberg Center for Health Sciences at Eisenhower

A Case-Based Roadmap for Improved Patient Outcomes in Psoriatic Arthritis

Patients with psoriatic arthritis (PsA) experience significant disease burden due to incomplete diagnostic evaluation and suboptimal use of effective therapies. In this case-based activity, Dr. Leonard Calabrese of the Cleveland Clinic addressing these practice gaps by sharing his recommendations for patient management at critical decision points in the diagnosis and treatment of patients with PsA. Dr. Calabrese also discusses the important role of shared decision-making over the course of the...
Annenberg Center for Health Sciences at Eisenhower

Update on Immunotherapeutic Strategies for Advanced Merkel Cell Carcinoma

STATEMENT OF NEED Merkel cell carcinoma is a rare and aggressive neuroendocrine tumor of unknown origin that typically presents in older white and immunocompromised adults. An estimated 2,488 cases are diagnosed in the United States annually (Paulson et al, 2018). The incidence of MCC has risen rapidly during the past few decades, which has been attributed in part to people living longer with increased sun exposure and weakened immune systems, a feature that suggests an infectious origin an...
i3 Health

New Data and Clinical Perspectives on the Treatment of Metastatic Hormone-Sensitive Prostate Cancer

STATEMENT OF NEED Prostate cancer is the most common tumor type affecting men in the United States. An estimated 191,930 new cases are diagnosed annually, and 33,330 people die from the disease (ACS, 2020). Most patients with metastatic hormone-sensitive prostate cancer (HSPC) present with relapse after local treatment, while approximately 5% of all prostate cancer patients present with de novo metastatic HSPC (Ng et al, 2020). The five-year overall survival rate for metastatic HSPC remains...
i3 Health

Metastatic Breast Cancer: Enhancing Treatment Tolerability, Adherence, and Patient-Centered Care

STATEMENT OF NEED Breast cancer accounts for approximately 30% of cancer diagnoses among women in the United States and is the second-leading cause of cancer death in this population (ACS, 2019). Although many women benefit from regular screening as well as earlier and improved treatment, approximately 6% present with metastatic disease, and up to 30% with no initial lymph node involvement eventually develop metastatic disease (Siegel et al, 2019; Mortensen et al, 2018). Women with MBC have...
i3 Health

Diagnosis, Treatment and Prevention Therapies in Primary Headache Disorders

ACTIVITY OVERVIEW Primary headache disorders are a major cause of disability and a common reason people seek medical care. However, distinguishing a primary from a secondary headache disorder, as well as among primary headache disorders, is often challenging. Focusing on cluster and migraine, Drs. Jessica Ailani and Stewart Tepper provide criteria and strategies to overcome this challenge in the office setting. Insight is also provided to help guide treatment with evidence-based medications a...
Annenberg Center for Health Sciences at Eisenhower

Sports Medicine 2022 -LIVE STREAMING

The Comprehensive 2022 Sports Medicine Update State-of-the-Art Approaches to the Diagnosis, Treatment, Rehabilitation, and Prevention of Sports Injuries This Harvard Medical School CME program, which is among the highest-rated HMS CME courses, provides a special and timely opportunity to hear directly from world-renowned physician specialists (physiatrists, orthopedists, radiologists), team physicians and athletic trainers for the Boston Red Sox, Boston Bruins, New England Revolution and New...
Harvard Medical School

Innovations and New Practices in Internal Medicine 2022 -LIVE STREAMING

The State of the Art in Internal Medicine This Harvard Medical School CME program provides a comprehensive update of the most important changes impacting Internal Medicine and guidance to incorporate these advances into everyday clinical practice to improve patient outcomes. Practical, Fast-Paced, Case-Based Education This streaming educational experience is fast paced, relevant to the current healthcare environment, and draws upon real-life cases. The course is designed and led by Harv...
Harvard Medical School

5th Annual Aspen Conference on Pediatric Cerebrovascular Disease and Stroke

Thought leaders in this emerging field will convene over the course of one week to share ideas, learn, and create pathways to deliver cutting edge care to pediatric and young adult cerebrovascular and stroke patients. Attendees will engage in discussion of cases, management nuances and protocol development in this field. Daily topics include: -Endovascular Management Options for Acute Stroke -Hemorrhagic Stroke and Head and Neck Vascular Malformations -Sickle cell related cerebrovascu...
Cincinnati Children's

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map